These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2100567)

  • 41. Significance of ferritin as a marker in head and neck malignancies.
    Bhatavdekar JM; Vora HH; Goyal A; Shah NG; Karelia NH; Trivedi SN
    Tumori; 1987 Feb; 73(1):59-63. PubMed ID: 3824534
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Optimizing treatment in head and neck cancers -- are molecular markers the answer?
    D'cruz AK; Mulherkar R
    Indian J Med Res; 2005 Sep; 122(3):196-8. PubMed ID: 16251774
    [No Abstract]   [Full Text] [Related]  

  • 43. [Clinical value of head and neck tumor markers].
    Gascón Vilaplana P
    Med Clin (Barc); 2007 Dec; 129(20):775-6. PubMed ID: 18093479
    [No Abstract]   [Full Text] [Related]  

  • 44. Effective head and neck tumor markers. The continuing quest.
    Ropka ME; Goodwin WJ; Levine PA; Sasaki CT; Kirchner JC; Cantrell RW
    Arch Otolaryngol Head Neck Surg; 1991 Sep; 117(9):1011-4. PubMed ID: 1910716
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Selected biochemical tumor markers in clinical monitoring of head and neck neoplasm progression].
    Adamiak G
    Otolaryngol Pol; 1999; 53(3):359-60. PubMed ID: 10481513
    [No Abstract]   [Full Text] [Related]  

  • 46. [Significance of magnetic resonance spectroscopy for diagnosis of head tumors].
    Reiman V; Holtmann S; Hamburger C; Hochstrasser K; Kastenbauer E
    Biomed Tech (Berl); 1990; 35 Suppl 3():254-5. PubMed ID: 2078721
    [No Abstract]   [Full Text] [Related]  

  • 47. Molecular markers in the head and neck cancers: are we there yet?
    Rath GK
    J Cancer Res Ther; 2013; 9(1):1-2. PubMed ID: 23575064
    [No Abstract]   [Full Text] [Related]  

  • 48. Biologic markers as predictors of risk in aerodigestive tract cancers.
    Trock B
    Adv Exp Med Biol; 1992; 320():47-54. PubMed ID: 1279956
    [No Abstract]   [Full Text] [Related]  

  • 49. Biochemical studies in head and neck cancer.
    Lal H
    Clin Biochem; 1994 Aug; 27(4):235-43. PubMed ID: 8001283
    [No Abstract]   [Full Text] [Related]  

  • 50. New biological markers may accurately predict prognosis in head and neck cancer patients.
    Oncology (Williston Park); 1998 Oct; 12(10):1537. PubMed ID: 9874584
    [No Abstract]   [Full Text] [Related]  

  • 51. Carcinomas of the head and neck.
    Cancer Treat Res; 1990; 52():3-282. PubMed ID: 1976371
    [No Abstract]   [Full Text] [Related]  

  • 52. TAF test: a new tumor marker?
    Taccone W; Belli M; Riccio M
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):55-8. PubMed ID: 1965449
    [No Abstract]   [Full Text] [Related]  

  • 53. Immunomodulatory serum components in head and neck cancer.
    Yamanaka N
    Eur J Cancer B Oral Oncol; 1993 Apr; 29B(2):103-6. PubMed ID: 8180585
    [No Abstract]   [Full Text] [Related]  

  • 54. [The volume of copper tape prints depending on room temperature].
    ILG VK
    Dtsch Zahnarztl Z; 1948 Apr; 3(7-8):301-7. PubMed ID: 18873387
    [No Abstract]   [Full Text] [Related]  

  • 55. Assessing renal function - searching for the perfect marker continues!
    Nair DR; Mehta S; Mikhailidis DP
    Arch Med Sci; 2011 Aug; 7(4):565-7. PubMed ID: 22291787
    [No Abstract]   [Full Text] [Related]  

  • 56. Tumor markers of head and neck carcinoma.
    Eibling DE; Wagner RL; Johnson JT
    Immunol Ser; 1990; 53():357-83. PubMed ID: 2100567
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The significance of ferritin, lipid-associated sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1 levels in SCC of the head and neck.
    Inal E; Laçin M; Asal K; Ceylan A; Köybaşioğlu A; Ileri F; Uslu SS
    Kulak Burun Bogaz Ihtis Derg; 2004; 12(1-2):23-30. PubMed ID: 16010093
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Study of Cyfra 21-1 as a new tumor marker for the diagnosis of epidermoid carcinoma of the head and neck].
    González Sánchez E; López-Ríos Velasco J; Calvo Boizas E; García-Talavera Fernández JR; Martín Ro-dríguez M; Muñoz Herrera A; Del Cañizo Alvarez A
    Acta Otorrinolaringol Esp; 1999 Mar; 50(2):85-9. PubMed ID: 10217679
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The diagnostic value of the tumor markers CEA, "Ca 19-9", "Ca 125", "Ca15-3" and "SCC" for the detection of recurrent tumors in patients with tumors of the head and neck].
    Zöller J; Fiehn W; Mende U; Hotz G
    Dtsch Z Mund Kiefer Gesichtschir; 1990; 14(4):254-9. PubMed ID: 2134649
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical protocols for the application of tests for circulating tumor markers.
    Bombardieri E; Buraggi GL
    Ann Ist Super Sanita; 1991; 27(3):541-6. PubMed ID: 1809077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.